RxDoctor Payments Data

James Witter, PA

Physician Assistant · David City, NENPI 1861421174

Payments from drug & device makers

$557in general payments, 2019–2025

Across 31 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$145
  • Actelion Pharmaceuticals US, Inc.$46
  • AstraZeneca$44
  • Lilly USA, LLC$24
  • Astellas Pharma US Inc$23
  • Alkermes, Inc.$23
  • plus $252 from 16 others

What the payments were for

  • Food & beverage$557100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$557 in reported general payments places this provider in the 60th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$5,447
Medicare patients
50
Services billed
119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban75$39,072
OzempicSemaglutide26$31,457
XareltoRivaroxaban26$15,848
JardianceEmpagliflozin15$13,993
Breo ElliptaFluticasone/Vilanterol12$4,637
Clobetasol Propionate25$4,247
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,158
Advair DiskusFluticasone Propion/Salmeterol13$2,510
Metoprolol Succinate133$1,783
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen123$1,726
Tamsulosin Hcl73$1,646
AliskirenAliskiren Hemifumarate12$1,427
Omeprazole137$1,364
Atorvastatin Calcium136$1,315
Gabapentin83$1,219

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$39,07275 claims
Novo NordiskOzempic$145$31,45726 claims
Johnson & JohnsonXarelto$15$15,84826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in David City

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →